Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter

More in Best Practice Series: Type 2 Diabetes

Compounds that effect GLP-1, GIP and DPP-4.

The Incretin Pathway: A new area of treatment for Type 2 diabetes.

Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the use of drugs that affect the incretin pathway in treating diabetes. Disclosures:Speaker’s...
Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses screening of various microvascular complications of type 2 diabetes and evaluates their...
Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the optimal use of insulin in treatment for diabetes. Disclosures:Speaker’s Bureau: Merck,...